We have developed a transdominant genetic methodology for isolating peptide, protein or RNA factors (collectively called peturbagens) that modulate biochemical targets within a cell to alter its pheno ...SBIR Phase I 2002 Department of Health and Human Services
DESCRIPTION (Verbatim from Applicant's Abstract):We have developed a technology for somatic cell genetics that leads rapidly to genetic agents that modulate cellular phenotypes. The techn ...SBIR Phase I 2001 Department of Health and Human Services
N/ASBIR Phase I 2000 Department of Health and Human Services
Not Available Over the past several years the Synthetic Environment Database Representation and Interchange Specification (SEDRIS) project has been developed to address the issues of simulation data ...SBIR Phase I 1999 Department of Health and Human Services
DELTAGEN PROTEOMICS, INC.
| DELTAGEN PROTEOMICS, INC.
615 ARAPEEN DR, STE 300
SALT LAKE CITY, UT, 84108
|Socially and Economically Disadvantaged:||N|
|Number of Employees:||n/a|